Company Profile
About Eli Lilly & Co. (LLY)
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Sector
PHARMACEUTICAL PREPARATIONS
Market Cap
$839.28B
Employees
50,000
Headquarters
INDIANAPOLIS, IN
Website
Latest Trading Data
Previous Close
$922.50
Open
$925.00
Day Range
$915.04 - $939.93
Volume
2,360,165